Malignant Edema (gas gangrene)

Malignant edema, commonly known as gas gangrene, is a rapidly progressive and frequently fatal clostridial infection affecting the soft tissues of livestock following wound contamination with pathogenic Clostridium species. This devastating condition occurs when bacterial spores present in the environment gain entry to tissues through wounds, surgical sites, injection areas, or other breaks in skin or mucosal integrity, germinating and proliferating in the anaerobic conditions of damaged tissues. The hallmark of malignant edema is the production of potent toxins and gas by the infecting bacteria, causing massive tissue destruction, severe systemic toxemia, and rapid death if not treated promptly and aggressively. Understanding the fulminant nature of this disease is critical for livestock producers and veterinarians to enable rapid recognition and intervention.

Malignant edema affects virtually all domestic livestock species including cattle, sheep, goats, pigs, and horses, as well as wild ruminants and other animals. The causative Clostridium species, primarily Clostridium septicum but also including Clostridium novyi, Clostridium chauvoei, Clostridium perfringens, and Clostridium sordellii, are ubiquitous soil organisms with spores capable of persisting in the environment for years. The condition occurs worldwide wherever livestock are raised, with incidence varying based on environmental contamination levels, vaccination practices, and the frequency of procedures or injuries that provide bacterial entry points. While exact prevalence figures are difficult to establish due to rapid progression and mortality, malignant edema represents a significant cause of sudden death in livestock.

The economic and welfare impact of malignant edema derives primarily from high case fatality rates and the typically sudden presentation that limits treatment opportunity. Affected animals frequently die within twelve to forty-eight hours of initial clinical signs becoming apparent, often before veterinary intervention can be obtained. The mortality rate in untreated or late-treated cases approaches one hundred percent. Beyond direct mortality losses, the disease causes significant animal suffering during its rapid progression, with affected individuals experiencing severe pain, toxemia, and systemic collapse. Fear of clostridial disease also drives significant investment in preventive vaccination programs, representing an ongoing cost even in herds without active disease.

The treatability of malignant edema depends almost entirely on the stage at which intervention begins, with early aggressive treatment offering some possibility of survival while delayed treatment is almost uniformly unsuccessful. The rapid tissue destruction and toxin production characteristic of clostridial infections mean that by the time clinical signs are obvious, irreversible damage has often already occurred. This reality makes prevention through vaccination and careful wound management far more effective than reliance on treatment. When treatment is attempted, it must be immediate, aggressive, and multimodal, combining high-dose antibiotics with surgical debridement and intensive supportive care. Even with optimal treatment, prognosis remains guarded to poor for most cases.

The primary cause of malignant edema is infection with toxin-producing Clostridium species, with Clostridium septicum representing the most common causative agent, though mixed infections and involvement of other clostridial organisms including Clostridium novyi, Clostridium chauvoei, Clostridium perfringens, and Clostridium sordellii occur regularly. These bacteria are gram-positive, spore-forming anaerobes that exist ubiquitously in soil and in the intestinal tract of herbivores, with spores capable of surviving in the environment for decades under favorable conditions. The pathogenic potential of these organisms lies in their production of potent exotoxins when germinating and proliferating in suitable anaerobic tissue environments. Different clostridial species produce different toxin profiles, leading to somewhat variable clinical presentations, though the overall disease syndrome remains consistent.

Genetic and breed predisposition does not play a significant role in malignant edema susceptibility, as the disease represents an environmental infection dependent on bacterial exposure rather than host genetics. However, individual variation in immune status does affect disease development, with animals that have received appropriate vaccination demonstrating significant protection against clinical disease. Animals with compromised immune function from concurrent disease, stress, or poor nutrition may be more susceptible to overwhelming infection following wound contamination. Age affects susceptibility primarily through vaccination status, as young animals may lack protection if vaccination programs are inadequate or if maternal antibody interference limits vaccine response.

Environmental and management factors play critical roles in determining malignant edema risk, with wound contamination representing the essential element in disease development. Wounds of all types provide potential entry points, including traumatic injuries from barbed wire, handling equipment, or other environmental hazards; surgical wounds from castration, dehorning, docking, or other procedures; injection sites particularly when contaminated needles or products are used; and birthing injuries affecting both dams and neonates. Environmental conditions that increase bacterial load, including contaminated corrals, muddy conditions, and areas where clostridial disease has previously occurred, elevate risk. Management practices that cause tissue trauma without appropriate attention to sterility and wound care create optimal conditions for clostridial invasion.

Specific risk factors that significantly increase malignant edema likelihood include any procedure or injury that creates wounds in contact with contaminated environments. Injections administered with contaminated equipment, using unsterile technique, or employing irritating products that cause tissue necrosis at injection sites create ideal anaerobic environments for clostridial growth. Castration and other surgical procedures performed under suboptimal conditions, particularly without attention to hemostasis and wound contamination, provide bacterial entry points. Difficult births with trauma to reproductive tissues, retained placentas with subsequent uterine contamination, and uterine procedures performed without appropriate hygiene increase risk in breeding females. Deep puncture wounds that carry contamination into tissues and then seal over, creating anaerobic conditions, are particularly dangerous.

The pathophysiology of malignant edema begins when clostridial spores contaminating a wound encounter the anaerobic conditions necessary for germination. Tissue trauma, devitalized tissue, hemorrhage, and foreign material all contribute to the anaerobic, nutrient-rich environment favoring clostridial growth. Once germination occurs, rapid bacterial multiplication produces powerful exotoxins including alpha-toxin with lecithinase activity that destroys cell membranes, various hemolysins causing blood cell destruction, collagenases breaking down connective tissue, and neuraminidases affecting tissue integrity. These toxins cause progressive tissue necrosis, extending the anaerobic environment and facilitating further bacterial spread. Gas production from bacterial metabolism causes the characteristic crepitus and tissue emphysema. Toxins entering systemic circulation produce the profound toxemia, cardiovascular collapse, and multi-organ failure that cause death.

Early warning signs of malignant edema are often subtle and rapidly progress to more obvious clinical illness, making early detection challenging but critically important. Initial signs may include mild lameness or stiffness if the infection involves limbs, decreased appetite, mild depression, or subtle behavioral changes such as separation from the group. Affected animals may show early swelling at the wound or injection site that is initially difficult to distinguish from normal post-procedural inflammation. Fever is typically present in early stages before toxemia produces hypothermia, and careful temperature monitoring of animals following procedures may enable early detection. Some animals demonstrate apparent discomfort or pain at the affected site before obvious swelling develops.

Common symptoms of established malignant edema progress rapidly and include both local tissue changes and systemic manifestations of toxemia. Local signs center on the affected area, with rapidly enlarging, hot, painful swelling that may initially be firm but becomes soft and fluid-filled as gas and fluid accumulate. The overlying skin becomes taut, discolored, and may develop a bronze or purplish appearance as tissue death progresses. Crepitus, a crackling sensation felt on palpation due to subcutaneous gas, is highly characteristic though not universally present. In cattle, the condition most commonly affects areas of the hindquarters, neck, or shoulder, while in sheep following shearing, large areas of the body wall may become involved. The swelling typically extends rapidly along tissue planes, sometimes visibly advancing over the course of hours.

Behavioral changes in animals with malignant edema reflect the severe systemic illness and pain associated with the condition. Affected animals demonstrate profound depression, stopping eating and showing minimal interest in their surroundings. They may be reluctant to move, standing with a stiff posture or becoming recumbent early in the disease course. Signs of pain including teeth grinding in ruminants, reluctance to bear weight on affected limbs, and vocalization may be present. As toxemia progresses, animals become increasingly obtunded and may show signs of shock including cold extremities, weak rapid pulse, and altered mentation.

Physical examination findings in malignant edema cases confirm the rapidly progressive soft tissue infection and associated systemic illness. Temperature is typically elevated early in the disease course but may fall below normal as circulatory collapse develops. Heart rate is elevated, and pulse quality deteriorates as cardiovascular function fails. Respiratory rate increases as the animal attempts to compensate for metabolic acidosis and tissue hypoxia. The affected area shows characteristic findings including extensive swelling that pits on pressure or feels emphysematous with gas accumulation. Discharge from wounds may be present, ranging from serosanguinous fluid to frank hemorrhage to foul-smelling necrotic material. Regional lymph nodes may be enlarged.

Symptom progression in malignant edema is alarmingly rapid, with cases often progressing from initial signs to death within twelve to forty-eight hours. Swelling expands rapidly, sometimes doubling in size over several hours as tissue destruction extends along fascial planes. The area of skin discoloration and necrosis expands correspondingly. Systemic signs of toxemia worsen progressively, with increasing depression, deteriorating cardiovascular function, and eventual recumbency. Terminal signs include profound shock with cold extremities, weak thready pulse, and labored breathing followed by collapse and death. Some animals are found dead without premonitory signs, having progressed through the entire disease course without observation.

Emergency symptoms requiring immediate veterinary intervention include any suspicion of clostridial infection based on rapidly progressive swelling at wound or injection sites, particularly when accompanied by systemic illness. The presence of crepitus in association with recent wounds or procedures is highly suggestive and warrants emergency response. Profound depression, fever followed by hypothermia, and cardiovascular collapse in animals with recent wounds demand immediate attention. Given the rapid progression and high fatality rate, any potential clostridial infection should be treated as a life-threatening emergency requiring immediate veterinary care.

Clinical examination provides the foundation for malignant edema diagnosis, with the characteristic presentation of rapidly progressive wound-associated soft tissue swelling combined with systemic toxemia being highly suggestive. Physical examination focuses on assessment of the affected area including extent of swelling, tissue consistency, presence of crepitus, skin color changes, and wound characteristics. Systemic assessment evaluates cardiovascular function through heart rate, pulse quality, and mucous membrane color and capillary refill time; respiratory status; temperature; and mental status. The combination of local findings with evidence of toxemia in an animal with recent wound or injection history strongly supports a presumptive diagnosis warranting immediate treatment.

Diagnostic tests can confirm diagnosis and identify the causative organism, though treatment should not be delayed pending results given the rapid progression of the disease. Gram stain and culture of material from affected tissues typically reveal gram-positive rods with or without spore formation, depending on the stage of bacterial growth. Fluorescent antibody testing can identify specific Clostridium species more rapidly than culture. Blood samples may reveal evidence of toxemia including abnormal leukocyte counts, elevated muscle enzymes from tissue destruction, and metabolic abnormalities reflecting shock and organ dysfunction. However, the primary utility of laboratory confirmation is often retrospective, informing prevention strategies and documentation rather than guiding immediate treatment.

Differential diagnosis for rapidly progressive soft tissue swelling includes several conditions that must be considered alongside malignant edema. Blackleg, caused by Clostridium chauvoei, produces similar clinical signs but classically affects young cattle without external wounds, arising from activation of endogenous spores in muscle. Injection site reactions without clostridial infection can cause significant swelling but typically lack the rapid progression, systemic toxemia, and gas production of malignant edema. Abscesses from other bacterial causes generally develop more slowly and cause less severe systemic illness. Snake envenomation in regions where venomous snakes are present can cause extensive local swelling and systemic effects. Severe trauma with secondary bacterial infection may produce overlapping signs but usually has clear traumatic history.

Herd-level diagnostics become relevant when multiple animals are affected or when patterns suggest common exposure sources. Investigation of vaccination protocols evaluates whether adequate protection against clostridial organisms exists in the affected population. Review of injection practices, surgical procedures, and wound management identifies potential contamination sources requiring correction. Environmental assessment may identify heavily contaminated areas contributing to disease risk. Post-mortem examination of affected animals that die provides definitive diagnosis through characteristic findings including extensive hemorrhagic soft tissue involvement, gas-filled tissues, and organism identification. Documentation of findings guides prevention strategies for remaining animals at risk.

Emergency treatment for malignant edema must begin immediately upon suspicion of diagnosis, as delays significantly worsen the already poor prognosis. High-dose antibiotic therapy targeting clostridial organisms should be initiated without waiting for laboratory confirmation, with penicillin historically considered the treatment of choice due to excellent activity against Clostridium species. Massive doses far exceeding normal therapeutic recommendations are often employed, with procaine penicillin G at doses of 22,000 to 44,000 IU per kilogram administered intramuscularly or intravenously as crystalline penicillin. Combination antibiotic therapy may be warranted to address potential mixed infections, and broad-spectrum coverage ensures activity against concurrent bacteria. Anti-inflammatory therapy helps address the inflammatory component of disease.

Medical management continues with repeated high-dose antibiotic administration over days to weeks, recognizing that even with aggressive therapy, prognosis remains guarded. Antibiotic selection should consider withdrawal time implications in food-producing animals, though the immediate priority must be saving the animal's life. Extra-label drug use under veterinary guidance with appropriate documentation and extended withdrawal periods may be necessary. Fluid therapy supports cardiovascular function and helps combat shock, administered intravenously in severely affected animals. Antitoxin products targeting specific clostridial toxins may provide benefit if administered early before extensive tissue binding occurs, though availability and efficacy vary. Supportive medications addressing pain, inflammation, and metabolic disturbances complement specific antimicrobial therapy.

Surgical intervention through aggressive debridement of affected tissues can be lifesaving when performed early and thoroughly. Extensive incision of affected areas exposes tissues to oxygen, disrupting the anaerobic environment necessary for clostridial growth. Excision of necrotic tissue removes both bacterial inoculum and toxin-producing organisms. Wound management following debridement includes leaving incisions open to prevent reestablishment of anaerobic conditions, lavage with appropriate solutions, and application of topical antiseptics. The extent of surgery required depends on the degree of tissue involvement, with limb amputation occasionally warranted for distal limb infections when this option is anatomically feasible and economically justifiable.

Supportive care measures address the systemic consequences of toxemia and support recovery during the prolonged healing period required following extensive tissue damage. Fluid therapy corrects dehydration and supports kidney function for toxin elimination. Nutritional support through enteral or parenteral means maintains strength when oral intake is reduced. Nursing care for recumbent animals prevents secondary complications including decubital ulcers and respiratory compromise. Wound care continues for weeks to months as extensive tissue defects heal by secondary intention. Physical therapy and rehabilitation may be necessary for animals with limb involvement.

Herd treatment protocols are generally not applicable for malignant edema given its wound-associated rather than contagious nature. However, when cases occur, review of management practices with implementation of improvements prevents additional cases. Prophylactic antibiotic administration may be considered for animals that underwent similar procedures or have similar wound risks. Vaccination status review with administration of clostridial vaccines to unprotected animals provides longer-term protection. Environmental management to reduce contamination in high-risk areas limits exposure of wounds to clostridial spores.

Treatment decisions for malignant edema must realistically address the poor prognosis even with optimal therapy. Early cases with limited local involvement and mild systemic signs may respond to aggressive treatment, justifying therapeutic attempts. Advanced cases with extensive tissue involvement, severe systemic illness, or delayed presentation carry extremely poor prognoses, and the welfare implications of prolonged aggressive treatment in such cases must be considered. Humane euthanasia may be the most appropriate option for severely affected animals to prevent continued suffering. Economic considerations also influence treatment decisions, particularly for commercial animals where treatment costs may exceed animal value. Veterinary guidance helps navigate these difficult decisions while prioritizing animal welfare.

Recovery timeline for the minority of malignant edema cases that survive is prolonged and complicated by the extensive tissue destruction characteristic of the disease. Animals that respond to treatment typically show stabilization of systemic signs within twenty-four to forty-eight hours of aggressive therapy initiation. Local tissue changes take much longer to resolve, with necrotic tissue requiring weeks to demarcate and slough. Complete healing of tissue defects through secondary intention may require months, with extensive scarring and tissue loss common outcomes. During this prolonged recovery period, continued monitoring and wound management remain essential to prevent secondary complications.

Post-treatment care and monitoring requirements reflect both the severity of the initial disease and the prolonged healing process following survival. Daily assessment of wound healing progress, detection of secondary infection, and monitoring for recurrence guide ongoing care. Wound management continues with regular debridement of necrotic tissue as it separates, lavage, and protective bandaging where feasible. Systemic monitoring ensures resolution of toxemia and addresses any metabolic or nutritional deficits that developed during acute illness. Antibiotic therapy typically continues for extended periods to prevent bacterial regrowth as tissues heal. Pain management supports comfort and encourages eating and normal behavior during recovery.

Prognostic factors affecting survival and recovery quality include the species and virulence of the causative Clostridium, the location and extent of tissue involvement, the promptness of treatment initiation, and the effectiveness of surgical debridement. Animals treated within hours of initial signs have better prognoses than those with advanced disease. Limited local involvement improves survival chances compared to extensive or multi-site infection. Involvement of vital structures including major blood vessels or body cavities dramatically worsens prognosis. Response to initial therapy, demonstrated by systemic stabilization and cessation of lesion progression, provides positive prognostic indication.

Return to production considerations for recovered animals depend on the extent of residual damage and the animal's intended use. Animals with extensive scarring or tissue loss may have cosmetic defects affecting show or sale value. Limb involvement with residual lameness may limit mobility for breeding or production purposes. Reproductive tract involvement in breeding females may compromise future fertility. Production losses during the prolonged recovery period represent significant economic impact in commercial operations. Documentation of disease history may be required for sale or marketing purposes in some situations.

Vaccination protocols represent the most effective prevention strategy for malignant edema, with highly effective multivalent clostridial vaccines widely available and recommended for all livestock. Standard seven-way or eight-way clostridial vaccines include protection against Clostridium septicum along with other important clostridial pathogens. Vaccination schedules typically recommend two initial doses two to four weeks apart for naive animals followed by annual boosters, though veterinary guidance on specific protocols for each operation is appropriate. Timing of vaccination should ensure protection before high-risk periods such as surgery, parturition, or movement to contaminated environments. Proper vaccine handling and storage maintaining cold chain integrity ensures vaccine potency.

Biosecurity measures for malignant edema prevention focus on reducing wound contamination with clostridial spores rather than preventing animal-to-animal transmission. Environmental management to reduce soil contamination levels in animal housing areas helps, though complete elimination of these ubiquitous organisms is impossible. Proper carcass disposal prevents concentration of spores in the environment, with burning or deep burial of animals dying from clostridial diseases recommended. Cleaning and disinfection of handling facilities between groups reduces environmental contamination. Limiting procedures to clean, dry conditions when possible reduces wound contamination risk.

Aseptic technique during procedures dramatically reduces malignant edema risk associated with injections, surgery, and other interventions. Injection protocols should emphasize proper skin preparation, use of sterile needles changed frequently, and appropriate injection site selection avoiding areas with heavy contamination. Surgical procedures require attention to sterile technique, adequate hemostasis, and appropriate wound management. Instruments should be properly cleaned and sterilized between animals. Injectable products should be handled according to manufacturer recommendations to prevent contamination. Training personnel in proper technique and monitoring compliance ensure consistent implementation.

Management practices that minimize wound occurrence and optimize wound care when injuries occur reduce malignant edema risk. Facility maintenance to eliminate sharp edges, protruding objects, and other hazards prevents traumatic injuries. Handling procedures that minimize stress and injury reduce wound occurrence during routine management activities. Prompt wound care including cleaning, disinfection, and monitoring of all injuries prevents bacterial establishment. Particular attention to birthing assistance technique and hygiene prevents introduction of infection into traumatized reproductive tissues.

Quarantine and testing protocols have limited application for malignant edema given its environmental rather than contagious nature. However, assessment of vaccination status for newly acquired animals ensures adequate protection before exposure to potentially contaminated premises. Animals with wounds or recent surgical procedures should be monitored carefully during the high-risk period following arrival. Isolation of animals showing early signs of possible clostridial infection enables intensive monitoring and rapid treatment while protecting other animals from exposure to bacterial shedding from affected tissues.

Daily management and monitoring for malignant edema prevention requires systematic attention to vaccination status, wound prevention, and early detection of affected animals. Record systems should track vaccination dates and ensure timely booster administration. Daily observation of animals should note any injuries requiring wound care and any animals showing early signs of illness that might indicate developing infection. Animals following recent procedures including injections, surgery, or difficult births require enhanced monitoring during the high-risk period of one to seven days post-procedure. Staff training on early recognition of clostridial disease signs enables rapid response when cases occur.

Housing and environmental management contributes to malignant edema prevention through reduction of both injury risk and environmental contamination. Facility design and maintenance should eliminate hazards that cause traumatic injuries. Flooring surfaces that prevent slipping and falling reduce trauma occurrence. Bedding management maintaining dry conditions reduces bacterial contamination of any wounds that occur. Drainage and manure management prevent accumulation of organic material that sustains clostridial populations. Areas where clostridial disease has occurred may remain heavily contaminated and warrant avoidance for animals with fresh wounds when possible.

Herd health programs should integrate clostridial disease prevention with overall management protocols. Written vaccination protocols specify products used, timing of initial series and boosters, and documentation requirements. Procedures requiring injection or surgery should have written protocols addressing aseptic technique, equipment handling, and post-procedure monitoring. Disease investigation protocols ensure appropriate response when cases occur, including necropsy examination, review of management practices, and adjustment of prevention protocols. Staff training programs ensure consistent implementation of preventive measures.

Record keeping and monitoring systems support evidence-based clostridial disease prevention. Individual animal vaccination records enable verification of protection status and identification of animals requiring vaccination. Incident documentation when cases occur captures circumstances that may identify correctable risk factors. Tracking of injection site reactions and surgical complications identifies problems with technique or products requiring attention. Analysis of disease occurrence patterns over time evaluates prevention program effectiveness and guides improvement efforts.

Economic considerations for malignant edema prevention strongly favor investment in vaccination and careful procedure technique over reliance on treatment of affected animals. The cost of vaccination programs represents minimal expense compared to the value of animals lost to clostridial disease. Training investments that improve technique for procedures reduce complications including clostridial infections. Cost-benefit analysis clearly demonstrates that prevention is far more cost-effective than treatment for these rapidly fatal diseases. Even considering the uncommon nature of malignant edema on well-managed operations, the catastrophic nature of cases when they occur justifies ongoing preventive investment.

Malignant edema does not show significant breed predilection, as susceptibility relates to wound contamination exposure and vaccination status rather than genetic factors. All breeds of cattle, sheep, goats, pigs, and horses are equally susceptible to clostridial wound infection when exposed to the causative organisms through appropriate wound contamination. Within species, management practices and vaccination programs determine disease risk more than breed characteristics. Some research suggests possible individual variation in immune response to clostridial vaccines, but this has not translated into breed-level susceptibility differences in practical settings.

Production type and management intensity influence malignant edema risk primarily through their effects on wound occurrence and vaccination practices. Extensively managed livestock may experience less handling-related injury but may also receive less consistent vaccination and wound care. Intensively managed operations perform more procedures that could introduce infection but typically maintain more rigorous vaccination and hygiene protocols. Breeding operations with parturition-related wound risks face different exposure patterns than finishing operations with injection-site risks. The specific risk profile varies with the management practices employed rather than the production type itself.

Genetic selection has no practical application for malignant edema prevention, as the disease reflects environmental exposure rather than heritable susceptibility. Unlike some clostridial diseases where genetic factors may influence muscle characteristics affecting blackleg susceptibility, malignant edema depends entirely on wound contamination. Selection for general immune function and disease resistance may provide modest benefit through improved vaccine response, but this represents an indirect and unproven approach. Prevention efforts should focus on vaccination compliance and wound management rather than genetic strategies.

Several conditions commonly co-occur with or share characteristics with malignant edema, requiring differentiation for appropriate management. Blackleg, caused by Clostridium chauvoei, produces similar gas-filled muscle lesions and systemic toxemia but classically affects young well-nourished cattle without external wounds, arising from endogenous spore activation following muscle trauma. Mixed clostridial infections involving multiple Clostridium species may occur, particularly in heavily contaminated wounds, and may produce clinical presentations combining features of different clostridial diseases. Injection site reactions ranging from sterile abscess to infected abscess to clostridial cellulitis represent a continuum requiring careful differentiation based on clinical progression and systemic involvement.

Conditions with similar clinical presentations that must be differentiated from malignant edema include various causes of soft tissue swelling and systemic illness. Severe trauma with tissue necrosis can produce local swelling without infection. Non-clostridial bacterial soft tissue infections including streptococcal and staphylococcal cellulitis typically progress more slowly and respond better to treatment. Snake envenomation in appropriate geographic regions can cause extensive swelling and tissue necrosis. Anthrax produces severe systemic illness with distinctive clinical and post-mortem findings. Allergic reactions to injections can cause dramatic swelling without the progressive tissue destruction and systemic toxemia of clostridial infection.

Complications and sequelae of malignant edema in surviving animals include extensive tissue loss requiring prolonged healing, significant scarring affecting appearance and function, and potential for secondary bacterial infections during the recovery period. Limb involvement may result in permanent lameness or necessitate amputation for survival. Abdominal wall involvement may result in herniation. Reproductive tract involvement may compromise future fertility. Survivors may develop enhanced immunity to the causative organism but remain susceptible to other clostridial species, emphasizing the importance of comprehensive multivalent vaccination for ongoing protection.